Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00412347 · ClinicalTrials.gov registry record

Insulin Infusion in the Hospital Wards

A clinical trial, sponsored by Emory University.

Completed
Registry status
200
Enrollment target

NCT00412347: Completed study, sponsored by Emory University.

NCT00412347 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00412347 has completed, sponsored by Emory University.

COMPLETED
Registry status
200 participants
Enrollment target

Study Summary

Increasing evidence from clinical studies in Intensive Care Unit (ICU) settings indicates that insulin infusion can improve outcome measures for patients with hyperglycemia (high blood sugar) independent of a previous diagnosis of diabetes mellitus. This improvement in health could also apply to patients that have high blood sugars in various other non-critical care areas of the hospital as well. However, the data that shows improvement in health outcomes has been collected from wards that have a lower patient to provider and patient to nurse ratio, resulting in the ability for a much tighter control of the insulin infusion. We hypothesize that tight blood glucose control will provide the same benefits for patients in non-intensive care units settings but that these protocols may lead to a higher incidence of hypoglycemia (low blood sugar) and potentially to adverse outcomes in patients. This study aims to determine the clinical outcome of patients treated with insulin infusion as well as the rate of hypoglycemic episodes in non-intensive areas. We will conduct a chart review of patients treated with insulin infusions in non-critical wards at Emory University Hospital during the period of 7/1/04 to 6/30/05. Medical records of all patients treated with intravenous insulin infusion protocols will be analyzed. Data on demographics, laboratory values, mortality rate, rate of hypoglycemic events, length of stay, as well as disposition at discharge will be analyzed.

Interventions

  • DRUG Insulin Drip Therapy

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2006-08
Est. Completion 2006-12
Emory University

1,208 total trials

What the finished NCT00412347 record still lists

NCT00412347 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Insulin Drip Therapy is the first listed.

NCT00412347 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00412347 about?

NCT00412347 is a clinical study titled "Insulin Infusion in the Hospital Wards". Increasing evidence from clinical studies in Intensive Care Unit (ICU) settings indicates that insulin infusion can improve outcome measures for patients with hyperglycemia (high blood sugar) independent of a previous diagnosis of diabetes mellitus. This improvement in health could also apply to pat...

What is the current status of trial NCT00412347?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2006-08. Estimated completion is 2006-12.

What interventions are being tested in trial NCT00412347?

The interventions under investigation include: Insulin Drip Therapy (DRUG).

Who is sponsoring clinical trial NCT00412347?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00412347, the US trial registry maintained by the National Library of Medicine. NCT00412347 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.